Skip to content

Net margin at other companies

Eli Lilly logo
Eli LillyLLY
35%+12.3pp
Pfizer logo
PfizerPFE
15.7%
Merck & Co. logo
Merck & Co.MRK
13.6%-13.7pp
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
35.5%
Cytokinetics logo
CytokineticsCYTK
-784%-337pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
101.6%+60.1pp

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
Enterprise value$976.73M+209%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Calculated from Lexicon Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's net margin?
Lexicon Pharmaceuticals (LXRX) reported net margin of -37.5% in Q1 2026.
How has Lexicon Pharmaceuticals's net margin changed year-over-year?
Lexicon Pharmaceuticals's net margin increased by 93.4% year-over-year, from -568% to -37.5%.
What is the long-term trend for Lexicon Pharmaceuticals's net margin?
Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's net margin has grown at a -16.2% compound annual growth rate (CAGR), from -244.1% to -101.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.